1 active not recruiting, 1 recruiting, 1 suspended, 1 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 1, Recruiting 1, Suspended 1, Terminated 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Radiotherapy, Image-Guided: new trials by email Literature Review of Radiotherapy, Image-Guided trials Research Report on Radiotherapy, Image-Guided
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer Biospecimen Collection, Cemiplimab, Computed Tomography - Eyelid Squamous Cell Carcinoma, Recurrent Eyelid Squamous Cell Carcinoma | Phase 3 | Suspended | National Cancer Institute (NCI) | 420 | 2025-02-18 | 2026-10-20 |
| Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer Carboplatin, Cisplatin, Computed Tomography - Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 | Phase 3 | Recruiting | NRG Oncology | 474 | 2023-07-12 | 2026-08-17 |
| De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Biopsy Procedure, Biospecimen Collection, Cisplatin - Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 / Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 384 | 2019-10-09 | 2026-07-02 |
| Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer Image Guided Radiation Therapy - Stage III Intrahepatic Cholangiocarcinoma, Stage IVA Intrahepatic Cholangiocarcinoma | Phase 3 | Terminated | NRG Oncology | 1 | 2014-09-29 | 2026-07-13 |
Carcinoma, Squamous Cell (1) · Cholangiocarcinoma (1) · Lung Neoplasms (1) · Oropharyngeal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
NRG Oncology (2) · National Cancer Institute (NCI) (2)
Canada (4) · United States (4) · Australia (1)
Charles B Simone (1) · Neil D Gross (1) · Sue S Yom (1) · Theodore Hong (1)
PMID 26503201, PMID 39615497, PMID 41137728
U10CA180868 (4)